4.7 Article

Increased risk of serious pneumococcal disease in patients with atopic conditions other than asthma

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 125, Issue 1, Pages 217-221

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2009.10.045

Keywords

Atopic dermatitis; allergic rhinitis; serious pneumococcal disease; epidemiology; risk; pneumococcal pneumonia; Rochester Epidemiology Project

Funding

  1. NIH [R01 AI 56133]
  2. National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR30582]
  3. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056133] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Background: We reported an increased risk of serious pneumococcal disease (SPD) among patients with asthma. It is not known whether this is true for patients with other atopic conditions. Objective: To determine the relationship between atopic conditions other than asthma and SPD. Methods: The study subjects were residents of Rochester, Minn, who developed SPD between 1964 and 1983 and their 2 sex-matched and age-matched controls. We used a population-based computer-linked medical diagnosis system to identify all individuals with potential SPD. All records were reviewed by using explicit predetermined criteria for SPD. All individuals with atopic conditions were identified by the physician diagnoses including atopic dermatitis or eczema, allergic rhinitis, and hay fever documented in medical records. The associations between these atopic conditions and SPD were assessed by using conditional logistic regression. Results: A total of 3941 records were reviewed, and we identified 174 SPD cases. Of these 174 cases, 50.6% were male, and 94.3% were Caucasian. Twenty-six (14.9%) of the SPD cases and 29 (8.3%) of the controls had atopy. Atopic conditions other than asthma were associated with an increased risk of SPD (odds ratio, 2.13; 95% CI, 1.04-4.35; P = .04) after adjusting for smoking status, previous high-risk conditions for SPD, educational status, and ethnicity. Conclusion: Like asthma, other atopic conditions, particularly atopic dermatitis, are associated with an increased risk of SPD. There may be a common immunogenetic mechanism underlying increased risk of SPD among individuals with either asthma or other atopic conditions. Our study findings need to be studied further. (J Allergy Clin Immunol 2010;125:217-21.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Public, Environmental & Occupational Health

Adverse family experiences and obesity in children and adolescents in the United States

Brian A. Lynch, Amenah Agunwamba, Patrick M. Wilson, Seema Kumar, Robert M. Jacobson, Sean Phelan, Valeria Cristiani, Chun Fan, Lila J. Finney Rutten

PREVENTIVE MEDICINE (2016)

Article Public, Environmental & Occupational Health

Younger age at initiation of the human papillomavirus (HPV) vaccination series is associated with higher rates of on-time completion

Jennifer L. St Sauver, Lila J. Finney Rutten, Jon O. Ebbert, Debra J. Jacobson, Michaela E. McGree, Robert M. Jacobson

PREVENTIVE MEDICINE (2016)

Review Immunology

The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches

Iana H. Haralambieva, Inna G. Ovsyannikova, V. Shane Pankratz, Richard B. Kennedy, Robert M. Jacobson, Gregory A. Poland

EXPERT REVIEW OF VACCINES (2013)

Article Immunology

Human Leukocyte Antigens and Cellular Immune Responses to Anthrax Vaccine Adsorbed

Inna G. Ovsyannikova, V. Shane Pankratz, Robert A. Vierkant, Nicholas M. Pajewski, Conrad P. Quinn, Richard A. Kaslow, Robert M. Jacobson, Gregory A. Poland

INFECTION AND IMMUNITY (2013)

Article Mathematical & Computational Biology

Assessing Agreement of Repeated Binary Measurements with an Application to the CDC's Anthrax Vaccine Clinical Trial

Yi Pan, Charles E. Rose, Michael Haber, Yan Ma, Josep L. Carrasco, Brock Stewart, Wendy A. Keitel, Harry Keyserling, Robert M. Jacobson, Gregory Poland, Michael M. McNeil

INTERNATIONAL JOURNAL OF BIOSTATISTICS (2013)

Article Multidisciplinary Sciences

Genome-Wide Characterization of Transcriptional Patterns in High and Low Antibody Responders to Rubella Vaccination

Iana H. Haralambieva, Ann L. Oberg, Inna G. Ovsyannikova, Richard B. Kennedy, Diane E. Grill, Sumit Middha, Brian M. Bot, Vivian W. Wang, David I. Smith, Robert M. Jacobson, Gregory A. Poland

PLOS ONE (2013)

Review Immunology

Vaccinomics, adversomics, and the immune response network theory: Individualized vaccinology in the 21st century

Gregory A. Poland, Richard B. Kennedy, Brett A. McKinney, Inna G. Ovsyannikova, Nathaniel D. Lambert, Robert M. Jacobson, Ann L. Oberg

SEMINARS IN IMMUNOLOGY (2013)

Article Immunology

Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: A randomized trial

Jennifer G. Wright, Brian D. Plikaytis, Charles E. Rose, Scott D. Parker, Janiine Babcock, Wendy Keitel, Hana El Sahly, Gregory A. Poland, Robert M. Jacobson, Harry L. Keyserling, Vera A. Semenova, Han Li, Jarad Schiffer, Hanan Dababneh, Sandra K. Martin, Stacey W. Martin, Nina Marano, Nancy E. Messonnier, Conrad P. Quinn

VACCINE (2014)

Article Primary Health Care

Asthma and the immune response to MMR vaccine viruses in Somali immigrant children: a cross-sectional retrospective cohort study

Apurvi R. Patel, John Zietlow, Robert M. Jacobson, Gregory A. Poland, Young J. Juhn

PRIMARY CARE RESPIRATORY JOURNAL (2013)

Editorial Material Pediatrics

Pre-Registration of Educational Trials: Should Educational Trials Be Expected to Be Conducted With the Same Rigor as Clinical Trials?

Su-Ting T. Li, Melissa Klein, Katherine A. Poehling, Robert M. Jacobson

ACADEMIC PEDIATRICS (2019)

Review Medicine, General & Internal

Routine Childhood Vaccines Given in the First 11 Months of Life

Robert M. Jacobson

MAYO CLINIC PROCEEDINGS (2020)

Article Biotechnology & Applied Microbiology

How health care providers should address vaccine hesitancy in the clinical setting: Evidence for presumptive language in making a strong recommendation

Robert M. Jacobson, Jennifer L. St Sauver, Joan M. Griffin, Kathy L. MacLaughlin, Lila J. Finney Rutten

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)

Review Medicine, General & Internal

Routine Childhood Vaccines Given From 1 through 18 Years of Age

Robert M. Jacobson

MAYO CLINIC PROCEEDINGS (2020)

Article Biotechnology & Applied Microbiology

The impact of provider recommendation on human papillomavirus vaccine and other adolescent vaccines

Alexandria C. Caldwell, Christi A. Madden, David M. Thompson, M. Connor Garbe, James R. Roberts, Robert M. Jacobson, Paul M. Darden

Summary: The study found that provider recommendation has a significant impact on adolescent vaccine coverage, particularly for the HPV vaccine. Vaccine coverage was generally higher among those who received a provider recommendation compared to those who did not.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Medicine, General & Internal

Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy

Lila J. Finney Rutten, Xuan Zhu, Aaron L. Leppin, Jennifer L. Ridgeway, Melanie D. Swift, Joan M. Griffin, Jennifer L. St Sauver, Abinash Virk, Robert M. Jacobson

Summary: The success of COVID-19 vaccination programs relies on scientific safety data, high acceptance rates, and population coverage. However, vaccine hesitancy and complacency about vaccination may undermine the success of these programs. Multilevel, evidence-based strategies are needed to address behavior change and vaccine hesitancy.

MAYO CLINIC PROCEEDINGS (2021)

No Data Available